PL BioScience
Signal active
Organization
Contact Information
Overview
STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
About
Industries
Biotechnology, Health Care
Founded
2015
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
PL BioScience headquartered in Europe, operates in the Biotechnology, Health Care sector. The company focuses on Biotechnology and has secured $208.7M in funding across 16 round(s). With a team of 1-10 employees, PL BioScience is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - PL BioScience, raised $8.5M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
6
Lead Investors
0
Total Funding Amount
$13.0M
Details
2
PL BioScience has raised a total of $13.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 4.5M | ||
| 2024 | Early Stage Venture | 8.5M |
Investors
PL BioScience is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Avant Bio | - | FUNDING ROUND - Avant Bio | 8.5M |
| TechVision Fund | - | FUNDING ROUND - TechVision Fund | 8.5M |
| PL BioScience | - | FUNDING ROUND - PL BioScience | 8.5M |
| Brightlands Venture Partners | - | FUNDING ROUND - Brightlands Venture Partners | 8.5M |
Recent Activity
There is no recent news or activity for this profile.